Table of Content

1 Market Overview of Anticoagulant Injections
1.1 Anticoagulant Injections Market Overview
1.1.1 Anticoagulant Injections Product Scope
1.1.2 Anticoagulant Injections Market Status and Outlook
1.2 Global Anticoagulant Injections Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anticoagulant Injections Market Size by Region (2018-2029)
1.4 Global Anticoagulant Injections Historic Market Size by Region (2018-2024)
1.5 Global Anticoagulant Injections Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anticoagulant Injections Market Size (2018-2029)
1.6.1 North America Anticoagulant Injections Market Size (2018-2029)
1.6.2 Europe Anticoagulant Injections Market Size (2018-2029)
1.6.3 Asia-Pacific Anticoagulant Injections Market Size (2018-2029)
1.6.4 Latin America Anticoagulant Injections Market Size (2018-2029)
1.6.5 Middle East & Africa Anticoagulant Injections Market Size (2018-2029)
2 Anticoagulant Injections Market by Type
2.1 Introduction
2.1.1 LMWH
2.1.2 Unfractionated Heparin
2.1.3 Fibrinolytics
2.1.4 Other
2.2 Global Anticoagulant Injections Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anticoagulant Injections Historic Market Size by Type (2018-2024)
2.2.2 Global Anticoagulant Injections Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anticoagulant Injections Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anticoagulant Injections Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anticoagulant Injections Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anticoagulant Injections Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anticoagulant Injections Revenue Breakdown by Type (2018-2029)
3 Anticoagulant Injections Market Overview by Application
3.1 Introduction
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Other
3.2 Global Anticoagulant Injections Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anticoagulant Injections Historic Market Size by Application (2018-2024)
3.2.2 Global Anticoagulant Injections Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anticoagulant Injections Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anticoagulant Injections Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anticoagulant Injections Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anticoagulant Injections Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anticoagulant Injections Revenue Breakdown by Application (2018-2029)
4 Anticoagulant Injections Competition Analysis by Players
4.1 Global Anticoagulant Injections Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2022)
4.3 Date of Key Players Enter into Anticoagulant Injections Market
4.4 Global Top Players Anticoagulant Injections Headquarters and Area Served
4.5 Key Players Anticoagulant Injections Product Solution and Service
4.6 Competitive Status
4.6.1 Anticoagulant Injections Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Anticoagulant Injections Products, Services and Solutions
5.1.4 Sanofi Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.1.5 Sanofi Recent Developments
5.2 Genentech (Roche)
5.2.1 Genentech (Roche) Profile
5.2.2 Genentech (Roche) Main Business
5.2.3 Genentech (Roche) Anticoagulant Injections Products, Services and Solutions
5.2.4 Genentech (Roche) Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.2.5 Genentech (Roche) Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Anticoagulant Injections Products, Services and Solutions
5.3.4 Boehringer Ingelheim Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.3.5 Aspen Recent Developments
5.4 Aspen
5.4.1 Aspen Profile
5.4.2 Aspen Main Business
5.4.3 Aspen Anticoagulant Injections Products, Services and Solutions
5.4.4 Aspen Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.4.5 Aspen Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Anticoagulant Injections Products, Services and Solutions
5.5.4 Pfizer Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.5.5 Pfizer Recent Developments
5.6 Hepalink
5.6.1 Hepalink Profile
5.6.2 Hepalink Main Business
5.6.3 Hepalink Anticoagulant Injections Products, Services and Solutions
5.6.4 Hepalink Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.6.5 Hepalink Recent Developments
5.7 King-friend
5.7.1 King-friend Profile
5.7.2 King-friend Main Business
5.7.3 King-friend Anticoagulant Injections Products, Services and Solutions
5.7.4 King-friend Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.7.5 King-friend Recent Developments
5.8 CSBIO
5.8.1 CSBIO Profile
5.8.2 CSBIO Main Business
5.8.3 CSBIO Anticoagulant Injections Products, Services and Solutions
5.8.4 CSBIO Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.8.5 CSBIO Recent Developments
5.9 Amphastar Pharmaceuticals
5.9.1 Amphastar Pharmaceuticals Profile
5.9.2 Amphastar Pharmaceuticals Main Business
5.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Products, Services and Solutions
5.9.4 Amphastar Pharmaceuticals Anticoagulant Injections Revenue (US$ Million) & (2018-2024)
5.9.5 Amphastar Pharmaceuticals Recent Developments
6 North America
6.1 North America Anticoagulant Injections Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Anticoagulant Injections Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Injections Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anticoagulant Injections Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Injections Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anticoagulant Injections Market Dynamics
11.1 Anticoagulant Injections Industry Trends
11.2 Anticoagulant Injections Market Drivers
11.3 Anticoagulant Injections Market Challenges
11.4 Anticoagulant Injections Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Anticoagulant Injections Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Anticoagulant Injections Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Anticoagulant Injections Market Size Share by Region (2018-2024)
Table 4. Global Anticoagulant Injections Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Anticoagulant Injections Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Anticoagulant Injections Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Anticoagulant Injections Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Anticoagulant Injections Revenue Market Share by Type (2018-2024)
Table 9. Global Anticoagulant Injections Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Anticoagulant Injections Revenue Market Share by Type (2024-2029)
Table 11. North America Anticoagulant Injections Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Anticoagulant Injections Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Anticoagulant Injections Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Anticoagulant Injections Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Anticoagulant Injections Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Anticoagulant Injections Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Anticoagulant Injections Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Anticoagulant Injections Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Anticoagulant Injections Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Anticoagulant Injections Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Anticoagulant Injections Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Anticoagulant Injections Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Anticoagulant Injections Revenue Market Share by Application (2018-2024)
Table 24. Global Anticoagulant Injections Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Anticoagulant Injections Revenue Market Share by Application (2024-2029)
Table 26. North America Anticoagulant Injections Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Anticoagulant Injections Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Anticoagulant Injections Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Anticoagulant Injections Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Anticoagulant Injections Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Anticoagulant Injections Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Anticoagulant Injections Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Anticoagulant Injections Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Anticoagulant Injections Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Anticoagulant Injections Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Anticoagulant Injections Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Anticoagulant Injections Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2022)
Table 39. Date of Key Players Enter into Anticoagulant Injections Market
Table 40. Global Anticoagulant Injections Key Players Headquarters and Area Served
Table 41. Anticoagulant Injections Product Solution and Service
Table 42. Global Anticoagulant Injections Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Sanofi Basic Information List
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Anticoagulant Injections Products, Services and Solutions
Table 47. Revenue (US$ Million) in Anticoagulant Injections Business of Sanofi (2018-2024)
Table 48. Sanofi Recent Developments
Table 49. Genentech (Roche) Basic Information List
Table 50. Genentech (Roche) Description and Business Overview
Table 51. Genentech (Roche) Anticoagulant Injections Products, Services and Solutions
Table 52. Revenue (US$ Million) in Anticoagulant Injections Business of Genentech (Roche) (2018-2024)
Table 53. Genentech (Roche) Recent Developments
Table 54. Boehringer Ingelheim Basic Information List
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Anticoagulant Injections Products, Services and Solutions
Table 57. Revenue (US$ Million) in Anticoagulant Injections Business of Boehringer Ingelheim (2018-2024)
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Aspen Basic Information List
Table 60. Aspen Description and Business Overview
Table 61. Aspen Anticoagulant Injections Products, Services and Solutions
Table 62. Revenue (US$ Million) in Anticoagulant Injections Business of Aspen (2018-2024)
Table 63. Aspen Recent Developments
Table 64. Pfizer Basic Information List
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Anticoagulant Injections Products, Services and Solutions
Table 67. Revenue (US$ Million) in Anticoagulant Injections Business of Pfizer (2018-2024)
Table 68. Pfizer Recent Developments
Table 69. Hepalink Basic Information List
Table 70. Hepalink Description and Business Overview
Table 71. Hepalink Anticoagulant Injections Products, Services and Solutions
Table 72. Revenue (US$ Million) in Anticoagulant Injections Business of Hepalink (2018-2024)
Table 73. Hepalink Recent Developments
Table 74. King-friend Basic Information List
Table 75. King-friend Description and Business Overview
Table 76. King-friend Anticoagulant Injections Products, Services and Solutions
Table 77. Revenue (US$ Million) in Anticoagulant Injections Business of King-friend (2018-2024)
Table 78. King-friend Recent Developments
Table 79. CSBIO Basic Information List
Table 80. CSBIO Description and Business Overview
Table 81. CSBIO Anticoagulant Injections Products, Services and Solutions
Table 82. Revenue (US$ Million) in Anticoagulant Injections Business of CSBIO (2018-2024)
Table 83. CSBIO Recent Developments
Table 84. Amphastar Pharmaceuticals Basic Information List
Table 85. Amphastar Pharmaceuticals Description and Business Overview
Table 86. Amphastar Pharmaceuticals Anticoagulant Injections Products, Services and Solutions
Table 87. Revenue (US$ Million) in Anticoagulant Injections Business of Amphastar Pharmaceuticals (2018-2024)
Table 88. Amphastar Pharmaceuticals Recent Developments
Table 89. North America Anticoagulant Injections Market Size by Country (2018-2024) & (US$ Million)
Table 90. North America Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 91. Europe Anticoagulant Injections Market Size by Country (2018-2024) & (US$ Million)
Table 92. Europe Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Anticoagulant Injections Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 94. Asia-Pacific Anticoagulant Injections Market Size by Region (2018-2024) & (US$ Million)
Table 95. Asia-Pacific Anticoagulant Injections Market Size by Region (2024-2029) & (US$ Million)
Table 96. Asia-Pacific Anticoagulant Injections Market Share by Region (2018-2024)
Table 97. Asia-Pacific Anticoagulant Injections Market Share by Region (2024-2029)
Table 98. Latin America Anticoagulant Injections Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Latin America Anticoagulant Injections Market Size by Country (2018-2024) & (US$ Million)
Table 100. Latin America Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 101. Middle East & Africa Anticoagulant Injections Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 102. Middle East & Africa Anticoagulant Injections Market Size by Country (2018-2024) & (US$ Million)
Table 103. Middle East & Africa Anticoagulant Injections Market Size by Country (2024-2029) & (US$ Million)
Table 104. Anticoagulant Injections Market Trends
Table 105. Anticoagulant Injections Market Drivers
Table 106. Anticoagulant Injections Market Challenges
Table 107. Anticoagulant Injections Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticoagulant Injections Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Anticoagulant Injections Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Anticoagulant Injections Market Share by Regions: 2022 VS 2029
Figure 4. Global Anticoagulant Injections Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Anticoagulant Injections Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Anticoagulant Injections Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Anticoagulant Injections Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Anticoagulant Injections Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Anticoagulant Injections Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of LMWH
Figure 11. Global LMWH Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Unfractionated Heparin
Figure 13. Global Unfractionated Heparin Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Fibrinolytics
Figure 15. Global Fibrinolytics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Other
Figure 17. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Global Anticoagulant Injections Market Size Share by Type: 2022 & 2029
Figure 19. North America Anticoagulant Injections Revenue Market Share by Type (2018-2029)
Figure 20. Europe Anticoagulant Injections Revenue Market Share by Type (2018-2029)
Figure 21. Asia-Pacific Anticoagulant Injections Revenue Market Share by Type (2018-2029)
Figure 22. Latin America Anticoagulant Injections Revenue Market Share by Type (2018-2029)
Figure 23. Middle East and Africa Anticoagulant Injections Revenue Market Share by Type (2018-2029)
Figure 24. VTE Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. ACS/MI Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. AF Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Global Anticoagulant Injections Market Size Share by Application: 2022 & 2029
Figure 29. North America Anticoagulant Injections Revenue Market Share by Application (2018-2029)
Figure 30. Europe Anticoagulant Injections Revenue Market Share by Application (2018-2029)
Figure 31. Asia-Pacific Anticoagulant Injections Revenue Market Share by Application (2018-2029)
Figure 32. Latin America Anticoagulant Injections Revenue Market Share by Application (2018-2029)
Figure 33. Middle East and Africa Anticoagulant Injections Revenue Market Share by Application (2018-2029)
Figure 34. Anticoagulant Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players Anticoagulant Injections Market Share in 2022
Figure 36. North America Anticoagulant Injections Market Share by Country (2018-2029)
Figure 37. U.S. Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 38. Canada Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 39. Germany Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 40. France Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 41. U.K. Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 42. Italy Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 43. Russia Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 44. Nordic Countries Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 45. Asia-Pacific Anticoagulant Injections Market Share by Region (2018-2029)
Figure 46. China Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 47. Japan Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 48. South Korea Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 50. India Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 51. Australia Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 52. Latin America Anticoagulant Injections Market Share by Country (2018-2029)
Figure 53. Mexico Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 54. Brazil Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa Anticoagulant Injections Market Share by Country (2018-2029)
Figure 56. Turkey Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 58. UAE Anticoagulant Injections Market Size (2018-2029) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report